What is the Cure Pharmaceutical Holding Corp. stock price forecast?

Cure Pharmaceutical Holding Corp. is currently trading at $3.11. View real-time AI analysis on Alpha Lenz.

What is Cure Pharmaceutical Holding Corp. insider trading activity?

View the latest insider trading data for Cure Pharmaceutical Holding Corp. on Alpha Lenz.

What is Cure Pharmaceutical Holding Corp.'s P/E ratio?

Cure Pharmaceutical Holding Corp.'s P/E ratio is 5.8.

Cure Pharmaceutical Holding Corp.

NYSE · IFIN

$3.11-0.17(-5.18%)Pre-market

Ask about Cure Pharmaceutical Holding Corp.'s future dividend policy...

Alpha Chat Insight

“Cure Pharmaceutical Holding Corp. trades at a P/E of 5.8 (undervalued) with modest ROE of 2.3%.”

Ask for details →

Company Overview

Cure Pharmaceutical Holding Corp. is a biopharmaceutical company focused on the development and commercialization of innovative drug delivery systems. It aims to improve patient adherence and experience by providing new methods for drug delivery, such as oral thin films and transdermal systems. Cure Pharmaceutical's technologies are designed to enhance the bioavailability, efficacy, and safety of existing pharmaceutical compounds while also providing a platform for new drug formulations. This plays a vital role in several therapeutic areas, including pain management, oncology, and central nervous system disorders. By leveraging cutting-edge technology and partnerships within the pharmaceutical industry, Cure Pharmaceutical Holding Corp. contributes to the advancement of personalized and precision medicine, addressing unmet medical needs and broadening the spectrum of delivery options in healthcare markets.

CEOMr. King Ong Kong

Websitehttps://investors.currencgroup.com

SectorTechnology

IndustrySoftware - Application

Employees244

Company Statistics

FY 2023

Profile

$18.14MMarket Cap

$0.00Revenue

0.00Shares Out

244Employees

Margins

N/AGross

N/AEBITDA

N/AOperating

N/APre-Tax

N/ANet

Valuation

5.76P/E

0.25P/B

N/AEV/Sales

-9.09EV/EBITDA

-32.81P/FCF

Growth (CAGR)

N/ARev 3Yr

N/ARev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

2.15%ROA

2.30%ROE

-1.38%ROIC

Financial Health

$43.51KCash & Cash Equivalents

$10.52MNet Debt

14.46%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Cure Pharmaceutical Holding Corp. trades at a P/E of 5.8 (undervalued) with modest ROE of 2.3%.”

Ask for details →

Frequently Asked Questions

Cure Pharmaceutical Holding Corp. (ticker: IFIN) is a company listed on NYSE in the Technology sector (Software - Application). It has approximately 244 employees. Market cap is $18M.

The current price is $3.11 with a P/E ratio of 5.76x and P/B of 0.25x.

ROE is 2.30%.